Recent Advances in the Development of Selective Anti-Atrial Fibrillation Drugs

Asia Pacific Cardiology
doi 10.15420/apc.2007:1:1:52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Radcliffe Group Ltd

Related search

Recent Advances in Oral Anticoagulation for Atrial Fibrillation

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2010English

Recent Advances in the Understanding and Management of Atrial Fibrillation: A Focus on Stroke Prevention

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Advances in Surgical Treatment of Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Nonsteroidal Anti-Inflammatory Drugs and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Expert Review of Cardiovascular Therapy
Internal MedicineMedicineCardiovascular MedicineCardiology
2015English

Non-Steroidal Anti-Inflammatory Drugs and the Risk of Atrial Fibrillation: A Population-Based Follow-Up Study

BMJ Open
Medicine
2014English

Recent Advances in Neural Development

F1000 Biology Reports
2009English

Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation

American Heart Journal
Cardiovascular MedicineCardiology
2013English

Stroke and Cardiovascular Events After Ablation or Anti-Arrhythmic Drugs for Treatment of Patients With Atrial Fibrillation

American Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Recent Progress in the Development of Osteoporosis Drugs

Spinal Surgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy